Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-02-26 @ 4:14 PM
Study NCT ID:
NCT03742102
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-14
First Post:
2018-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Triple Negative Breast Neoplasms | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | View |
| None | PD-L1 high TNBC | View |
| None | Breast Cancer | View |
| None | TNBC | View |
| None | Triple Negative | View |
| None | Triple Negative Breast Cancer | View |
| None | Triple-Negative Breast Cancer | View |
| None | Triple-Negative Breast Neoplasm | View |
| None | ER-Negative PR-Negative HER2-Negative Breast Cancer | View |